Program
You can access the Interactive Program of WoM 2020 by clicking on the button above.
Below you can find a Program at a Glance.
By registering for the WoMDMH 20 Conference, you will also have access to the co-located World of Microbiome: Pregnancy, Birth & Infancy (WoMPBI 20) Confenrence. Both WoM Conferences will have a common exhibition and networking area, and you will have access to the scientific content of the two tracks and the option to attend WoMPBI 20 sessions and participate in discussions.
To preview the Preliminary program of the WoMPBI 20, please follow this link: https://microbiome-pbi.kenes.com/program/
*the Program is Preliminary and is a subject to change.
The Conference will be held in Central European TIme (CET UTC+1).
Please note all live sessions are scheduled in the afternoons, for the convenience of delegates from both Europe and the Americas.
Pre-registration and separate payment is required.
16:00 - 16:45: Introduction to QIIME 2
16:45 - 18:00: Hands-on tutorial
18:00 - 18:30: Break
18:30 - 19:30: Hands-on tutorial
19:30 - 20:30: Open Questions & Answers session
The Conference will be held in Central European TIme (CET UTC+1).
Please note all live sessions are scheduled in the afternoons, for the convenience of delegates from both Europe and the Americas.
The antibiotic crisis: beyond resistance
Martin Blaser, Rutgers University, USA
Host microbiome interactions in health and disease
Eran Elinav, Weizmann Institute of Science, Israel
Enabling gut microbiome research globally
Gregory Caporaso, Northern Arizona University, USA
Fungi and bacteria in IBD pathogenesis
Harry Sokol, Sorbonne Université, France
The role of genetic factors in shaping the intestinal microbiome - from large-scale GWAS to mQTL studies
Andre Franke, University of Kiel, Germany
The role of the microbiome in causing depression and other psychiatric problems in IBD patients and beyond
Luc Biedermann, University of Zurich, Switzerland
Fatigue, IBD and metabolome
Nynke Borren, Massachusetts General Hospital, USA
Gut microbiota & recurrence of post-operative Crohn's disease
Irit Avni-Biron, Rabin Medical Center, Israel
Genetic and microbial associations to plasma and fecal bile acids in obese humans relate to plasma lipids and liver fat content
Lianmin Chen, Netherlands
Host-genetics, dysbiosis and clinical history explains fecal metabolic alterations in patients with inflammatory bowel disease
A. Vich Vila, Netherlands
The role of the gut microbiome in mediating lactose intolerance symptoms
M. Brandao Gois, Netherlands
A novel bio-engineered probiotic designed to persist in the colon protects against colitis by restoring immune and metabolic balance
Andrea Alejandra Verdugo Meza, Canada
Maternal probiotic supplementation does not perturb the breast milk microbiota or gut colonization in preterm infants
H. Hiltunen, Finland
Short break
Microbiome-epithelial interaction and implications
Jonathan Braun, Cedars Sinai Medical Center, USA
The influence of commonly used non-antibiotics on the gut microbiome
Rinse Weersma, University Medical Center Groningen, Netherlands
Personalized medicine based on microbiome and clinical data
Eran Segal, Weizmann Institute of Science, Israel
Microbial changes and modification in patients after pouch surgery
Uri Gophna, Tel Aviv University, Israel
Panel Discussion - LIVE FORUM
Josbert Keller, Haaglanden MC, Netherlands
Alisa Hart, St Mark’s Academic Institute, UK
Gregory Caporaso, Northern Arizona University, USA
Harry Sokol, Sorbonne Université, France
Andre Franke, University of Kiel, Germany
Nynke Borren, Massachusetts General Hospital, USA
Irit Avni-Biron, Rabin Medical Center, Israel
The Conference will be held in Central European TIme (CET UTC+1).
Please note all live sessions are scheduled in the afternoons, for the convenience of delegates from both Europe and the Americas.
Tumour control
Michael Scharl, University of Zurich, Switzerland
The Microbiome in Primary Sclerosing Cholangitis
Christoph Schramm, University Medical Center Hamburg, Germany
The gut-liver axis in chronic liver diseases
Vanessa Stadlbauer, Medical University of Graz, Austria
Psychosocial factors and microbiota: from hypothesis to facts
Dan Lucian Dumitrascu, University of Medicine and Pharmacy “Iuliu Haţieganu“, Romania
A National Donor Feces Bank for treatment and research beyond Costridioides difficile infections
Ed Kuijper, Leiden University Medical Center, Netherlands
Roots of FMT
Ilan Youngster, Shamir Medical Center, Israel
Gut pathobionts and alcohol-associated liver disease
Bernd Schnabl, University of California San Diego, USA
New forms of intestinal inflammation affected by the microbiome
Iris Dotan, Rabin Medical Center, Israel
Lunch Break
How the microbiome is changed by diet
Lihi Godny, Rabin Medical Center, Israel
Wide-scale antibiotic use for prevention in population-based settings: what would it mean to gut microbiota? The case of H.pylori screen-and-treat strategy
Marcis Leja, University of Latvia, Latvia
Designing diagnostics and therapeutics for the gut microbiome
David Riglar, Imperial College London, UK
Panel Discussion - LIVE FORUM
Industry session
Industry session not included in main event CME/CPD credit
e-Poster session on Topic 6: Other
Christoph Schramm, University Medical Center Hamburg, Germany
Vanessa Stadlbauer, Medical University of Graz, Austria
Dan Lucian Dumitrascu, University of Medicine and Pharmacy “Iuliu Haţieganu“, Romania
Ed Kuijper, Leiden University Medical Center, Netherlands
Ilan Youngster, Shamir Medical Center, Israel
Bernd Schnabl, University of California San Diego, USA
Short Break
Topic 1: The importance of clear definitions for probiotics, prebiotics, synbiotics, postbiotics and fermented foods for scientific, commercial and regulatory communities.
Probiotics and fermented foods
Mary Ellen Sanders, Dairy & Food Culture Technologies, USA
Postbiotics
Gabriel Vinderola, National University of Litoral, Argentina
Prebiotics and synbiotics
Glenn Gibson, University of Reading, UK
Topic 2: State of recommendations for these products
“Biotics” for paediatric use
Hania Szajewska, Medical University of Warsaw, Poland
Probiotics for adults
Dan Merenstein, Georgetown University, USA
Panel Discussion - LIVE FORUM
Panellists:Mary Ellen Sanders, USA, Gabriel Vinderola, Argentina, Glenn Gibson,UK, Hania Szajewska, Poland, Dan Merenstein, USA, Olga Sakwinska, Switzerland, Ella Schaefer, Switzerland
Closure
